Biomaterial Database

[Inhibitors of coagulation and fibrinolysis in diabetics]. 1988

E Tóthová, and J Mechír, and B Mudronová, and D Petrásová

UI	MeSH Term	Description	Entries
D008297	Male		Males
D008875	Middle Aged	An adult aged 45 - 64 years.	Middle Age
D001777	Blood Coagulation	The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot.	Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D003920	Diabetes Mellitus	A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260	Female		Females
D005340	Fibrinogen	Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products.	Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D005342	Fibrinolysis	The natural enzymatic dissolution of FIBRIN.	Fibrinolyses
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328	Adult	A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.	Adults
D000511	alpha-Macroglobulins	Glycoproteins with a molecular weight of approximately 620,000 to 680,000. Precipitation by electrophoresis is in the alpha region. They include alpha 1-macroglobulins and alpha 2-macroglobulins. These proteins exhibit trypsin-, chymotrypsin-, thrombin-, and plasmin-binding activity and function as hormonal transporters.	Slow alpha 2-Macroglobulins,alpha 2-Acute Phase Globulins,alpha-Macrofetoproteins,45S RNP,Acute-Phase alpha 1-Protein,Slow alpha 2-Globulin,alpha 1-Acute Phase Globulin,alpha 1-Acute Phase Protein,alpha 1-Macroglobulin,alpha 2-Acute Phase Globulin,alpha-Macrofetoprotein,Acute Phase alpha 1 Protein,RNP, 45S,Slow alpha 2 Globulin,Slow alpha 2 Macroglobulins,alpha 1 Acute Phase Globulin,alpha 1 Acute Phase Protein,alpha 1 Macroglobulin,alpha 1-Protein, Acute-Phase,alpha 2 Acute Phase Globulin,alpha 2 Acute Phase Globulins,alpha 2-Globulin, Slow,alpha 2-Macroglobulins, Slow,alpha Macrofetoprotein,alpha Macrofetoproteins,alpha Macroglobulins

Related Publications

E Tóthová, and J Mechír, and B Mudronová, and D Petrásová

[Inhibitors of coagulation and of fibrinolysis].

January 1985, Sangre,

E Tóthová, and J Mechír, and B Mudronová, and D Petrásová

Normal blood coagulation, fibrinolysis, and natural inhibitors of coagulation.

January 1985, International anesthesiology clinics,

E Tóthová, and J Mechír, and B Mudronová, and D Petrásová

Coagulation activation, fibrinolysis and inhibitors in neonates.

November 1997, Annals of the Academy of Medicine, Singapore,

E Tóthová, and J Mechír, and B Mudronová, and D Petrásová

Coagulation, fibrinolysis and fibrinolysis inhibitors in haemodialysis patients: contribution of arteriovenous fistula.

July 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,

E Tóthová, and J Mechír, and B Mudronová, and D Petrásová

Coagulation disorders in cancer. 3. Fibrinolysis and inhibitors.

April 1970, Cancer,

E Tóthová, and J Mechír, and B Mudronová, and D Petrásová

Interrelation between inhibitors of blood coagulation and of fibrinolysis.

January 1962, Thrombosis et diathesis haemorrhagica,

E Tóthová, and J Mechír, and B Mudronová, and D Petrásová

Control of coagulation and fibrinolysis by plasma proteinase inhibitors.

August 1983, Behring Institute Mitteilungen,

E Tóthová, and J Mechír, and B Mudronová, and D Petrásová

Factors and inhibitors of blood coagulation and fibrinolysis in promyelocytic leukemia.

January 1985, Scandinavian journal of clinical and laboratory investigation. Supplementum,